Indeed, looking at the most variable genes in the immune compartment of the TME before and after ACT, a core IFNγ response gene set (for example, Cxcl9, Gbp2 and Slamf7) was strongly increased in NTT tumours. The gene discussed is CXCL9; the disease is neoplasm.